JGC
CYTK icon

J. Goldman & Co’s Cytokinetics CYTK Stock Holding History

J. Goldman & Co’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$791K Sell
12,007
-5,638
-32% -$358K 0.04% 451
2025
Q4 		$1.12M Buy
17,645
+3,140
+22% +$195K 0.04% 372
2025
Q3 		$797K Sell
14,505
-19,131
-57% -$788K 0.03% 349
2025
Q2 		$1.11M Buy
+33,636
New +$1.17M 0.03% 332
2024
Q4 		– Hold
0
– – – 518
2024
Q3 		– Hold
0
– – – 512
2024
Q1 		– Sell
-8,095
Closed -$676K – 446
2023
Q4 		$676K Sell
8,095
-52,194
-87% -$1.89M 0.04% 255
2023
Q3 		$1.78M Sell
60,289
-2,387
-4% -$79.5K 0.09% 209
2023
Q2 		$2.04M Sell
62,676
-42,913
-41% -$1.59M 0.12% 207
2023
Q1 		$3.72M Buy
+105,589
New +$4.31M 0.22% 169

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return